Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Immunome, Inc. Banner

Immunome, Inc.

IMNM Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Net Income
-7.845m-10.444m-17.837m-24.711m-36.896m-106.806m
Depreciation & Amortization
521.000K615.000K755.000K755.000K631.000K728.000K
Change in Working Capital
-102.000k212.000K-1.209m2.778M2.243M11.997M
Operating Cash Flow
-7.406m-9.600m-12.134m-18.226m-28.690m-7.568m
Capital Expenditure
-228.000k-233.000k-586.000k-79.000k-248.000k-831.000k
Free Cash Flow
-7.634m-9.833m-12.720m-18.305m-28.938m-8.399m
Debt Repayment
-551.000k-612.000k-451.000k-113.000k0.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
0.0004.621M44.850M27.881M32.000K-8.592m
Common Stock Repurchased
0.000-35.000k-49.000k0.0000.0000.000
Net Change in Cash
-8.185m941.000K37.223M9.463M-28.906m78.356M